HK1145455A1 - Combinations of an anti-cancer agent and a cholestanol derivative - Google Patents

Combinations of an anti-cancer agent and a cholestanol derivative

Info

Publication number
HK1145455A1
HK1145455A1 HK10111957.6A HK10111957A HK1145455A1 HK 1145455 A1 HK1145455 A1 HK 1145455A1 HK 10111957 A HK10111957 A HK 10111957A HK 1145455 A1 HK1145455 A1 HK 1145455A1
Authority
HK
Hong Kong
Prior art keywords
combinations
cancer agent
cholestanol derivative
cholestanol
derivative
Prior art date
Application number
HK10111957.6A
Other languages
English (en)
Inventor
Shin Yazawa
Toyo Nishimura
Takayuki Asao
Original Assignee
Otsuka Pharma Co Ltd
Univ Gunma Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ Gunma Nat Univ Corp filed Critical Otsuka Pharma Co Ltd
Publication of HK1145455A1 publication Critical patent/HK1145455A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10111957.6A 2008-03-05 2010-12-21 Combinations of an anti-cancer agent and a cholestanol derivative HK1145455A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008055284 2008-03-05
PCT/JP2009/000985 WO2009110235A1 (ja) 2008-03-05 2009-03-04 コレスタノール誘導体の併用用途

Publications (1)

Publication Number Publication Date
HK1145455A1 true HK1145455A1 (en) 2011-04-21

Family

ID=41055800

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10111957.6A HK1145455A1 (en) 2008-03-05 2010-12-21 Combinations of an anti-cancer agent and a cholestanol derivative

Country Status (27)

Country Link
US (6) US8088744B2 (xx)
EP (1) EP2251014B8 (xx)
JP (1) JP5336466B2 (xx)
KR (1) KR20100120674A (xx)
CN (2) CN101678037B (xx)
AR (1) AR070857A1 (xx)
AU (1) AU2009220699C1 (xx)
BR (2) BRPI0908756A2 (xx)
CA (1) CA2717135A1 (xx)
CO (2) CO6311080A2 (xx)
CY (1) CY1115217T1 (xx)
DK (1) DK2251014T3 (xx)
ES (1) ES2437640T3 (xx)
HK (1) HK1145455A1 (xx)
HR (2) HRP20140154T1 (xx)
IL (1) IL207874A (xx)
MX (1) MX2010009794A (xx)
NZ (2) NZ587729A (xx)
PL (1) PL2251014T3 (xx)
PT (1) PT2251014E (xx)
RU (1) RU2492865C2 (xx)
SG (2) SG188805A1 (xx)
SI (1) SI2251014T1 (xx)
TW (1) TWI492759B (xx)
UA (2) UA101831C2 (xx)
WO (1) WO2009110235A1 (xx)
ZA (1) ZA201006228B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2384744A1 (en) * 2004-01-14 2011-11-09 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
JP5480241B2 (ja) * 2009-03-04 2014-04-23 大塚製薬株式会社 コレスタノール誘導体の併用用途
NZ594996A (en) * 2009-03-04 2014-02-28 Otsuka Pharma Co Ltd Cholestanol derivative for combined use
WO2013179310A1 (en) * 2012-05-31 2013-12-05 Mylan Laboratories Limited Stable aqueous compositions of pemetrexed
WO2024018412A1 (en) * 2022-07-20 2024-01-25 University Of The Witwatersrand, Johannesburg 2-hydroxypropyl-beta-cyclodextrin as a cancer therapy neoadjuvant or adjuvant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5782310A (en) 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
JPS6012127A (ja) 1983-06-30 1985-01-22 Dai Ichi Seiyaku Co Ltd リポソ−ムの製法
JPS6058915A (ja) 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JPH0610131B2 (ja) 1987-10-30 1994-02-09 テルモ株式会社 リポソームの製法
JPH01167218A (ja) 1987-12-22 1989-06-30 Sumitomo Electric Ind Ltd 超電導薄膜の作製方法
JPH082780B2 (ja) 1990-05-28 1996-01-17 テルモ株式会社 リポソームの製法
JP3831958B2 (ja) 1995-09-20 2006-10-11 日本油脂株式会社 リポソーム用混合脂質及びリポソーム分散液
JP4105258B2 (ja) 1997-08-19 2008-06-25 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
JP4351314B2 (ja) 1998-12-24 2009-10-28 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
EE200200565A (et) * 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
EP1647277A4 (en) * 2003-07-17 2011-09-21 Otsuka Pharma Co Ltd LIPOSOME CONTAINING GLYCOSIDE
CA2548491A1 (en) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Synergistic anti-cancer compositions
ES2309765T3 (es) * 2004-05-28 2008-12-16 4Sc Ag Tetrahidropiridotiofenos.
TWI373473B (en) 2005-09-02 2012-10-01 Otsuka Pharma Co Ltd Anticancer agent

Also Published As

Publication number Publication date
US20150374730A1 (en) 2015-12-31
AU2009220699B2 (en) 2013-06-20
CN101969961A (zh) 2011-02-09
SG188805A1 (en) 2013-04-30
SG10201400171PA (en) 2014-06-27
CY1115217T1 (el) 2017-01-04
EP2251014A4 (en) 2012-05-23
BRPI0908756A2 (pt) 2015-07-21
NZ595615A (en) 2013-06-28
RU2492865C2 (ru) 2013-09-20
CO6361931A2 (es) 2012-01-20
PL2251014T3 (pl) 2014-04-30
AR070857A1 (es) 2010-05-12
US20100062053A1 (en) 2010-03-11
HRP20150418T1 (hr) 2015-05-08
ES2437640T3 (es) 2014-01-13
EP2251014A1 (en) 2010-11-17
EP2251014B8 (en) 2014-01-08
SI2251014T1 (sl) 2014-02-28
AU2009220699C1 (en) 2014-01-16
IL207874A (en) 2014-05-28
JP5336466B2 (ja) 2013-11-06
CN101678037B (zh) 2012-07-25
US20130101679A1 (en) 2013-04-25
CN101678037A (zh) 2010-03-24
KR20100120674A (ko) 2010-11-16
ZA201006228B (en) 2011-11-30
CO6311080A2 (es) 2011-08-22
NZ587729A (en) 2012-03-30
US20120015025A1 (en) 2012-01-19
PT2251014E (pt) 2014-02-14
EP2251014B1 (en) 2013-11-20
HRP20140154T1 (hr) 2014-03-14
JPWO2009110235A1 (ja) 2011-07-14
TW200940097A (en) 2009-10-01
US20140178464A1 (en) 2014-06-26
MX2010009794A (es) 2010-12-21
US8088744B2 (en) 2012-01-03
CN101969961B (zh) 2013-01-16
TWI492759B (zh) 2015-07-21
US20120009251A1 (en) 2012-01-12
WO2009110235A1 (ja) 2009-09-11
BRPI0924525A2 (pt) 2016-03-01
IL207874A0 (en) 2010-12-30
UA101831C2 (uk) 2013-05-13
CA2717135A1 (en) 2009-09-11
UA101884C2 (uk) 2013-05-13
DK2251014T3 (da) 2013-12-02
AU2009220699A1 (en) 2009-09-11
RU2010140611A (ru) 2012-04-10

Similar Documents

Publication Publication Date Title
HK1243713A1 (zh) 一種化合物的固體形式及其使用方法
EP2445894A4 (en) KETAL COMPOUNDS AND USES THEREOF
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
HK1148686A1 (en) Vitamin e derivatives and their uses
GB0818498D0 (en) Provision of inserts
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
HK1144319A1 (en) Compositions and methods of detecting tiabs
IL213974A0 (en) Isoxazole-isoxazole and isoxazole-isothiazole derivatives
EP2356462A4 (en) ANTI-CXCR1 COMPOSITIONS AND METHOD
EP2200638A4 (en) TRANSFECTION PROCEDURES AND COMPOSITIONS FOR THIS
ZA201204347B (en) New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
ZA201008553B (en) Steroidal compounds as melanogenesis modifiers and uses thereof
HK1145455A1 (en) Combinations of an anti-cancer agent and a cholestanol derivative
EP2490541A4 (en) 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE
EP2460812A4 (en) STEROL DERIVATIVES AND THEIR SYNTHESIS AND USE
EP2502627A4 (en) ANTI CANCER AGENTS
IL208824A0 (en) Iminopyridine derivative and use thereof
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
EP2274294A4 (en) 5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES
EP2162253A4 (en) NEARLY LIQUID RHEOFORMS OF INJECTABLE ALLOY
IL214319A (en) Chemotherapeutic agent for cancer containing cholesterol derivative and anticancer agent
EP2457923A4 (en) sterol derivative
GB2453140B (en) A method of activating a composition
IL206950A0 (en) Aminopiperidinyl derivatives and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180304